EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY 4.0

Efficacy and safety of tacrolimus combined with low-dose glucocorticoids vs. high-dose glucocorticoids in initial treatment of adult-onset minimal change disease: a retrospective cohort study

Xiaotao Ma, Jiayi Li, Xia Yang, Baoling Li, Tian Yao, Lifang Tian, Fuqian Lei, Xiaoyong Yu, Shohida Naimova, Sui Lin Cao, Rongguo Fu

PeerJ · 13.04.2026 · 14 · e21089

DOI: 10.7717/peerj.21089 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift PeerJ, online erschienen am 13.04.2026. Verfasst von Xiaotao Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Tacrolimus, Glucocorticoids, Nephrosis, Lipoid, Immunosuppressive Agents. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Shaanxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The treatment of adult minimal change disease (MCD) is challenging due to the side effects of high-dose and long-term glucocorticoid therapy as well as the frequent relapsing of the disease. Clinically, there is a demand for regimens that ensure rapid response and lower relapse rates, such as calcineurin inhibitors could fulfill this role. This study aims to compare the efficacy and safety of tacrolimus combined with low-dose glucocorticoids vs. high-dose glucocorticoids in the treatment of newly diagnosed adult MCD.

Methods

A retrospective cohort study was conducted on 59 adult patients diagnosed with MCD via renal biopsy at the Second Affiliated Hospital of Xi’an Jiaotong University, China. Patients were divided into two groups: the high-dose glucocorticoids group (GCs group, 39 patients, receiving 1 mg/kg/day prednisone) and the tacrolimus combined with low-dose glucocorticoid group (TAC group, 20 patients, receiving 0.05 mg/kg/day tacrolimus plus 10 mg/day prednisone). Both groups were followed for at least 24 weeks. The primary endpoint was the complete remission rate at 24 weeks, with secondary endpoints including relapse rates. And adverse events was analysed.

Results

At 24 weeks, the complete remission rates (90% vs . 100%, p = 0.111) and cumulative relapse rates (5% vs . 25.6%, p = 0.054) were comparable between the TAC and GCs groups. Patients receiving high-dose glucocorticoids were more likely to show incurred higher Cushingoid features (41% vs . 5%, p = 0.004). Patients in the tacrolimus group had a higher risk of transient serum creatinine elevation (10% vs . 0%, p = 0.045), resolving spontaneously. Longitudinal albumin recovery and estimated glomerular filtration rate (eGFR) stability were similar between groups.

Conclusions

Tacrolimus combined with low-dose glucocorticoids demonstrates comparable efficacy to high-dose glucocorticoids in inducing remission for adult-onset MCD, with a more favorable safety profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusGlucocorticoidsNephrosis, LipoidImmunosuppressive AgentsPrednisoneHumansRetrospective StudiesFemaleMaleAdultMiddle AgedDrug Therapy, CombinationTreatment OutcomeRemission InductionYoung AdultDose-Response Relationship, DrugRecurrence

Stichwörter der Autor:innen

AdultGlucocorticoidsMinimal change diseaseNephrotic syndromeTacrolimus

Substanzen

TacrolimusGlucocorticoidsImmunosuppressive AgentsPrednisone

Autor:innen und Institutionen

  • Department of Nephrology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Department of Nephrology, Shaanxi Traditional Chinese Medicine Hospital, Xi'an, Shaanxi, China.
  • Department of Nephrology, Bukhara State Medical Institute, Bukhara, Uzbekistan.
  • Department of Nephrology, Xi'an Gaoxin Hospital, Xi'an, Shaanxi, China.

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Shaanxi

Zitieren

APA

Ma, X., Li, J., Yang, X., Li, B., Yao, T., Tian, L., Lei, F., Yu, X., Naimova, S., Cao, S. L., & Fu, R. (2026). Efficacy and safety of tacrolimus combined with low-dose glucocorticoids vs. high-dose glucocorticoids in initial treatment of adult-onset minimal change disease: a retrospective cohort study. PeerJ, 14, e21089. https://doi.org/10.7717/peerj.21089

Vancouver

Ma X, Li J, Yang X, Li B, Yao T, Tian L, et al. Efficacy and safety of tacrolimus combined with low-dose glucocorticoids vs. high-dose glucocorticoids in initial treatment of adult-onset minimal change disease: a retrospective cohort study. PeerJ. 2026;14:e21089. doi:10.7717/peerj.21089

BibTeX
@article{Ma2026,
  author = {Ma, Xiaotao and Li, Jiayi and Yang, Xia and Li, Baoling and Yao, Tian and Tian, Lifang and Lei, Fuqian and Yu, Xiaoyong and Naimova, Shohida and Cao, Sui Lin and Fu, Rongguo},
  title = {Efficacy and safety of tacrolimus combined with low-dose glucocorticoids vs. high-dose glucocorticoids in initial treatment of adult-onset minimal change disease: a retrospective cohort study},
  journal = {PeerJ},
  year = {2026},
  volume = {14},
  pages = {e21089},
  doi = {10.7717/peerj.21089}
}
Kostenlos starten →